The Elder Care Market: Products and Services

  • ID: 3632366
  • Report
  • 164 pages
  • BCC Research
20 % OFF
until Jun 30th 2018
1 of 4
The U.S. Eldercare Market is Forecast to Reach $512.7 billion in 2020, Demonstrating a CAGR of 4.2% from 2015 to 2020
This report provides a broad background on the structure of the U.S. elder care healthcare market and the chief issues it faces. It offers the information needed to understand the current market and to address the emerging one. Comparisons with the elder care market in Europe, Asia and developing countries are provided. Projections provided through 2020.

This report provides:

- An overview of the global markets for eldercare products and services.
- Analyses of market trends, with data from 2014, estimates for 2015, and projections of CAGRs through 2020.
- Segmentations of the market into healthcare products and services, housing services and needs, and assistive technologies.
- Breakdowns of the U.S. and worldwide markets by demographics.
- A focus on applications including:
-- Heart disease/stroke.
-- Cancer treatments.
-- Kidney disease medications.
-- Diabetes medications.
-- Arthritis prescription medications.
-- Osteoporosis medications.
-- Pain medications.
-- Neurological health medications (e.g., dementia, depression).
-- Respiratory medications and products.
- Information covering the industry's structure.
- Profiles of major players in the industry.

Scope of the Report:

This report offers forecasts by product segment (i.e., healthcare, housing, and assistive devices and technology) from 2015 through 2020, including supporting analyses for projections.

Report segments include a demographic background of the market in the U.S. and worldwide, healthcare products and services, housing services and needs, and assistive technologies for the elder care market. International markets are discussed and information is provided on industry structure.

Profiles of leading companies involved in the elder care pharmaceutical, housing and assistive device industries are provided. Information on company placement within the designated market and strategic analyses of the companies’ available and emerging products are discussed.

Study Goals and Objectives:

The aim of this report is to provide an in-depth analysis and forecast of the healthcare, housing and assistive device segments of the U.S. elder care market. The report will focus on the size of the U.S. market, with comparisons to other markets in developed countries in Europe and Asia.

Demographic implications, funding implications for individuals and countries, products and services currently available in the housing and assistive device markets, and research regarding future healthcare treatments will be discussed. Future healthcare treatments will concentrate on the areas of concern for individuals who are older than 65, including:

- Arthritis prescription medications
- Cardiovascular, heart disease/stroke
- Cancer treatments
- Diabetes medication
- Sensory impairments
- Neurological health medications (e.g., dementia, depression)
- Liquid nutritional supplements
- Osteoporosis medications and orthopedic impairment surgery
- Respiratory medications and products
- Urological (incontinence, benign prostatic hyperplasia).

Use this report to:

- Identify current and future products and opportunities, and their impact on global market.
- Assess current trends and market data for various product segments essentially healthcare, housing, and assistive devices and technology.
- Gain insight into healthcare, housing and assistive device segments of the U.S. elder care market.
- Identify emerging companies with profiles of their leadership and an update on M&A activity

Highlights:

- The U.S. eldercare market reached $381.6 billion in 2014 and nearly $417 billion in 2015. The market should reach $512.7 billion in 2020, demonstrating a compound annual growth rate (CAGR) of 4.2% from 2015 to 2020.
- Home remodeling services had the highest market value at $237.8 billion in 2014 and $255.8 billion in 2015. The market should reach $310.3 billion in 2020, a CAGR of 3.9%.
- The U.S. elder care market for assistive technologies totaled $6.2 billion in 2015, and should reach nearly $8.0 billion by 2020, a CAGR of 5.1%.

Intended Audience:

This report provides a broad background on the structure of the U.S. elder care healthcare market and the chief issues it faces. It offers the information needed to understand the current market and to address the emerging one. Comparisons with the elder care market in Europe, Asia and developing countries are provided.

This is an invaluable tool for business planners, acquisitions specialists, licensing strategists, product managers, investor consultants and others interested in the elder care market, its products, participants and future.
READ MORE
Note: Product cover images may vary from those shown
2 of 4
Chapter- 1: INTRODUCTION
- STUDY GOALS AND OBJECTIVES
- REASONS FOR DOING THE STUDY
- SCOPE OF REPORT
- INTENDED AUDIENCE
- INFORMATION SOURCES
- ANALYST'S CREDENTIALS

Chapter- 2: SUMMARY
- EMPHASIS OF THE REPORT

Chapter- 3: OVERVIEW OF GLOBAL ELDERLY POPULATION
- DEFINITIONS
- TRENDS IN GLOBAL AGING
- THE GLOBAL ENVIRONMENT FOR THE ELDERLY
- THE ELDERLY IN THE U.S.
- GOVERNMENT LEGISLATION AND PROGRAMS AIMED AT THE ELDERLY
- U.S. GOVERNMENT-SPONSORED AND PRIVATELY SPONSORED NUTRITION PROGRAMS
- END-OF-LIFE CONSIDERATIONS

Chapter- 4: INDUSTRY TRENDS BY SECTOR - HEALTHCARE
- U.S. HEALTHCARE FOR INDIVIDUALS OVER 65
- ARTHRITIS
- CARDIOVASCULAR DISEASES
- CANCER
- DIABETES
- SENSORY IMPAIRMENTS
- NEUROLOGICAL DISEASES
- LIQUID NUTRITIONAL SUPPLEMENTS
- ORTHOPEDIC
- RESPIRATORY
- OTHER CHRONIC CONDITIONS
- ACQUISITIONS AND MERGERS IN THE ELDER CARE PHARMACEUTICAL INDUSTRY

Chapter- 5: INDUSTRY TRENDS BY SECTOR - HOUSING
- UNPAID CAREGIVERS
- LONG-TERM CARE
- U.S. HOUSING FOR INDIVIDUALS OVER 65
- MARKET ANALYSIS
- AT-HOME REMODELING
- HOME HEALTHCARE SERVICES
- ADULT DAY CENTERS
- HOUSING FOR LOWER INCOME INDIVIDUALS
- INSTITUTIONAL CARE ALTERNATIVES FOR SENIORS
- ASSISTED LIVING, SKILLED NURSING, MEMORY CARE PROVIDERS
- TOP INDUSTRY PROVIDERS
- ASSISTED LIVING
- SKILLED NURSING HOMES
- MARKET CONSTRAINTS
- INDEPENDENT LIVING
- INDEPENDENT LIVING/ACTIVE ADULT COMMUNITIES
- SENIOR HOUSING MARKET OPPORTUNITIES

Chapter- 6: INDUSTRY TRENDS, BY SECTOR - ASSISTIVE TECHNOLOGIES
- PROJECTED ASSISTIVE TECHNOLOGIES MARKET
- ASSISTIVE TECHNOLOGIES MARKET ANALYSIS FOR INDIVIDUALS OVER 65
- MEDICAL AND PERSONAL MONITORING AIDS
- ACCESS AIDS
- DAILY LIVING AIDS
- MOBILITY AIDS
- OTHER AIDS

Chapter- 7: DEVELOPMENTAL PIPELINE FOR ELDER CARE PHARMACEUTICALS
- CANCER
- DIABETES
- EYE DISEASES
- HEART DISEASE/STROKE
- KIDNEY DISEASE
- MUSCULOSKELETAL
- NEUROLOGICAL
- RESPIRATORY
- Table 76 : MEDICINES IN DEVELOPMENT FOR SELECTED THERAPEUTIC AREAS, 2014

Chapter- 8: COMPANY DIRECTORY
- HEALTHCARE
- MEDICAL DEVICES
- HOUSING OPTIONS
- ASSISTIVE DEVICES

Chapter- 9: GLOSSARY
- ACTIVITIES OF DAILY LIVING (ADLS)
- ALZHEIMER'S DISEASE
- ARTHRITIS
- ASSISTED LIVING
- ASSISTIVE TECHNOLOGY
- BABY BOOMER
- CARDIOVASCULAR DISEASE
- CAREGIVERS
- CONGESTIVE OBSTRUCTIVE PULMONARY DISEASE (COPD)
- DEMENTIA
- DIABETES
- DURABLE MEDICAL EQUIPMENT
- ELDER/SENIOR
- GERONTOLOGY
- HOSPICE CARE
- INSTRUMENTAL ACTIVITIES OF DAILY LIVING (IADLS)
- LONG-TERM CARE
- PROSTHETICS AND ORTHOTICS

List of Tables

Summary Table : U.S. MARKET FOR INDIVIDUALS OVER 65 BY TYPE OF NEED, THROUGH 2020
Table 1 : PERCENT OF POPULATION AGE 65 AND OLDER IN SELECTED COUNTRIES, 2014
Table 2 : ESTIMATED ELDERLY POPULATIONS COMPARED WITH OVERALL POPULATIONS, WITH PERCENT OF POPULATION BY U.S. STATE, 2014
Table 3 : U.S. MARKET FOR HEALTHCARE MEDICATIONS, PRODUCTS AND SURGICAL PROCEDURES FOR INDIVIDUALS OVER 65 BY CONDITION, THROUGH 2020
Table 4 : U.S. MARKET FOR PRESCRIPTION ARTHRITIS MEDICATIONS FOR INDIVIDUALS OVER 65, THROUGH 2020
Table 5 : SELECTED LISTING OF HEART DISEASE MEDICATIONS BY BRAND NAME AND MANUFACTURER
Table 6 : U.S. MARKET FOR CARDIOVASCULAR DISEASE MEDICATIONS, THROUGH 2020
Table 7 : U.S. MARKET FOR CARDIOVASCULAR MEDICATIONS FOR INDIVIDUALS OVER 65, THROUGH 2020
Table 8 : LEADING CANCER DRUG PRODUCTS, BY MANUFACTURER AND INDICATION, 2015
Table 9 : U.S. MARKET FOR CANCER TREATMENT DRUGS, THROUGH 2020
Table 10 : U.S. MARKET FOR CANCER DRUGS FOR INDIVIDUALS OVER AGE 65, THROUGH 2020
Table 11 : SULFONYLUREAS
Table 12 : BIGUANIDES
Table 13 : ORAL HYPOGYCEMICS
Table 14 : TOP DIABETES DRUGS, BY DRUG AND MANUFACTURER
Table 15 : U.S. MARKET FOR DIABETES MEDICATIONS AND MONITORING PRODUCTS, THROUGH 2020
Table 16 : U.S. MARKET FOR DIABETES MEDICATIONS AND MONITORING PRODUCTS FOR INDIVIDUALS OVER 65, THROUGH 2020
Table 17 : U.S. MARKET FOR SENSORY IMPAIRMENT PHARMACEUTICALS AND PRODUCTS FOR INDIVIDUALS OVER 65 BY TYPE, THROUGH 2020
Table 18 : ESTIMATED NUMBER OF CASES BY VISION PROBLEM FOR INDIVIDUALS OVER 40, 2010-
Table 19 : U.S. MARKET FOR PRESCRIPTION DRUGS AND SURGERY TO TREAT EYE DISEASES IN INDIVIDUALS OVER 65 BY CONDITION, THROUGH 2020
Table 20 : U.S. MARKET FOR PRODUCTS TO TREAT AMD FOR INDIVIDUALS OVER 65, THROUGH 2020
Table 21 : U.S. MARKET FOR CATARACT SURGERY FOR INDIVIDUALS OVER 65, THROUGH 2020
Table 22 : U.S. MARKET FOR GLAUCOMA PRESCRIPTION MEDICATIONS FOR INDIVIDUALS OVER 65, THROUGH 2020
Table 23 : U.S. MARKET FOR EYEWEAR FOR INDIVIDUALS OVER 65, THROUGH 2020
Table 24 : U.S. MARKET FOR HEARING AID PRODUCTS FOR INDIVIDUALS OVER 65, THROUGH 2020
Table 25 : U.S. MARKET FOR DEMENTIA AND DEPRESSION MEDICATIONS FOR INDIVIDUALS OVER 65 BY DISEASE, THROUGH 2020
Table 26 : COMMON PRESCRIPTION MEDICATIONS FOR ALZHEIMER'S DISEASE, 2015
Table 27 : U.S. MARKET FOR DEMENTIA MEDICATIONS FOR INDIVIDUALS OVER 65, THROUGH 2020
Table 28 : U.S. MARKET FOR DEPRESSION MEDICATIONS FOR INDIVIDUALS OVER 65, THROUGH 2020
Table 29 : U.S. MARKET FOR LIQUID NUTRITIONAL SUPPLEMENTS FOR INDIVIDUALS OVER 65, THROUGH 2020
Table 30 : U.S. MARKET FOR ORTHOPEDIC MEDICATIONS AND SURGERIES FOR INDIVIDUALS OVER 65 BY CONDITION, THROUGH 2020
Table 31 : UNCONTROLLABLE AND CONTROLLABLE RISK FACTORS FOR OSTEOPOROSIS
Table 32 : OSTEOPOROSIS MEDICATIONS BY TYPE
Table 33 : U.S. MARKET FOR OSTEOPOROSIS MEDICATIONS FOR INDIVIDUALS OVER 65, THROUGH 2020
Table 34 : U.S. MARKET FOR SELECTED ORTHOPEDIC SURGERY FOR INDIVIDUALS OVER 65, THROUGH 2020
Table 35 : U.S. MARKET FOR RESPIRATORY MEDICATIONS AND PRODUCTS FOR INDIVIDUALS OVER 65, THROUGH 2020
Table 36 : CURRENT ALLERGY TREATMENTS
Table 37 : U.S. MARKET FOR PRESCRIPTION ALLERGY MEDICATIONS FOR INDIVIDUALS OVER 65 BY TYPE, THROUGH 2020
Table 38 : U.S. MARKET FOR ASTHMA MEDICATIONS FOR INDIVIDUALS OVER 65, THROUGH 2020
Table 39 : U.S. MARKET FOR COPD MEDICATIONS FOR INDIVIDUALS OVER 65, THROUGH 2020
Table 40 : CURRENT TREATMENT OPTIONS FOR ASTHMA/COPD IN U.S.
Table 41 : U.S. MARKET FOR HOME OXYGEN AND RESPIRATORY SUPPLIES FOR INDIVIDUALS OVER 65, THROUGH 2020
Table 42 : MAJOR ASTHMA/COPD DRUGS LOSING PATENT PROTECTION BETWEEN 2014-2021
Table 43 : U.S. MARKET FOR UROLOGICAL PRODUCTS FOR INDIVIDUALS OVER 65 BY CONDITION, THROUGH 2020
Table 44 : U.S. MARKET FOR INCONTINENCE MEDICATIONS FOR INDIVIDUALS OVER 65, THROUGH 2020
Table 45 : SELECTED MEDICATIONS FOR BPH
Table 46 : U.S. MARKET FOR BPH MEDICATIONS FOR INDIVIDUALS OVER 65, THROUGH 2020
Table 47 : SELECTED ACQUISITIONS AND MERGERS IN THE ELDER CARE PHARMACEUTICAL MARKET, 2013 TO 2015
Table 48 : LONG-TERM INSURANCE CARRIERS, 2015
Table 49 : U.S. MARKET FOR SENIOR HOUSING AND DAY SERVICES FOR INDIVIDUALS OVER 65, THROUGH 2020
Table 50 : U.S. MARKET FOR AT-HOME REMODELING FOR INDIVIDUALS OVER 65, THROUGH 2020
Table 51 : U.S. MARKET FOR HOME HEALTH SERVICES FOR INDIVIDUALS OVER 65, THROUGH 2020
Table 52 : U.S. MARKET FOR ADULT DAY CARE SERVICES FOR INDIVIDUALS OVER 65, THROUGH 2020
Table 53 : U.S. MARKET FOR ASSISTED LIVING AND SKILLED NURSING FACILITIES FOR INDIVIDUALS OVER 65 BY SERVICE, THROUGH 2020
Table 54 : TOP 10 ASSISTED LIVING PROVIDERS IN U.S. BY CAPACITY, 2014
Table 55 : TOP 10 INDEPENDENT LIVING PROVIDERS BY CAPACITY, 2014
Table 56 : TOP FIVE MEMORY CARE LIVING PROVIDERS IN THE U.S., 2015
Table 57 : SELECTED ACQUISITIONS AND MERGERS IN THE SENIOR HOUSING MARKET, 2013-2015
Table 58 : U.S. MARKET FOR INDEPENDENT LIVING HOUSING FOR INDIVIDUALS OVER 65, THROUGH 2020
Table 59 : U.S. ASSISTIVE TECHNOLOGY MARKET BY TYPE, THROUGH 2020
Table 60 : U.S. MARKET FOR ASSISTIVE TECHNOLOGIES FOR INDIVIDUALS OVER 65 BY TYPE, THROUGH 2020
Table 61 : U.S. MARKET FOR MEDICAL/PERSONAL MONITORING AIDS FOR INDIVIDUALS OVER 65, THROUGH 2020
Table 62 : ACCESS AIDS MANUFACTURERS
Table 63 : U.S. MARKET FOR ACCESS AIDS FOR INDIVIDUALS OVER 65, THROUGH 2020
Table 64 : SELECTED MANUFACTURERS OF DAILY LIVING AIDS
Table 65 : U.S. MARKET FOR DAILY LIVING AIDS FOR INDIVIDUALS OVER 65, THROUGH 2020
Table 66 : U.S. MARKET FOR MOBILITY PRODUCTS FOR INDIVIDUALS OVER 65 BY PRODUCT, THROUGH 2020
Table 67 : WHEELCHAIR MANUFACTURERS
Table 68 : SCOOTER MANUFACTURERS
Table 69 : U.S. MARKET FOR AMBULATORY AIDS FOR INDIVIDUALS OVER 65, THROUGH 2020
Table 70 : AMBULATORY AID MANUFACTURERS
Table 71 : U.S. MARKET FOR MOTOR VEHICLE MODIFICATIONS FOR INDIVIDUALS OVER 65, THROUGH 2020
Table 72 : VEHICLE ASSESS CONVERSION KIT MANUFACTURERS
Table 73 : U.S. MARKET FOR NAVIGATION AIDS FOR INDIVIDUALS OVER 65, THROUGH 2020
Table 74 : U.S. MARKET FOR OTHER AIDS FOR INDIVIDUALS OVER 65 BY TYPE OF AID, THROUGH 2020
Table 75 : U.S. MARKET FOR COMMUNICATION AIDS FOR INDIVIDUALS OVER 65, THROUGH 2020
Table 76 : MEDICINES IN DEVELOPMENT FOR SELECTED THERAPEUTIC AREAS, 2014
Table 77 : MAJOR PRODUCT PIPELINES FOR BREAST CANCER
Table 78 : MAJOR PRODUCT PIPELINES FOR COLORECTAL CANCER
Table 79 : MAJOR PRODUCT PIPELINES FOR BLADDER CANCER
Table 80 : MAJOR PRODUCT PIPELINES FOR PROSTATE CANCER
Table 81 : MAJOR PRODUCT PIPELINES FOR SKIN CANCER
Table 82 : MAJOR PRODUCT PIPELINES FOR DIABETES
Table 83 : MAJOR PRODUCT PIPELINE FOR EYE DISEASES
Table 84 : MAJOR PRODUCT PIPELINES FOR HEART DISEASE/STROKE
Table 85 : MAJOR PRODUCT PIPELINES FOR KIDNEY DISEASE
Table 86 : MAJOR PRODUCT PIPELINES FOR OSTEOPOROSIS
Table 87 : MAJOR PRODUCT PIPELINES FOR RHEUMATOID ARTHRITIS
Table 88 : MAJOR PRODUCT PIPELINES FOR DEPRESSION
Table 89 : MAJOR PRODUCT PIPELINE FOR DEMENTIA PHARMACEUTICALS
Table 90 : MAJOR PRODUCT PIPELINES FOR ASTHMA
Table 91 : MAJOR PRODUCT PIPELINES FOR COPD

List of Figures

Summary Figure : U.S. MARKET FOR INDIVIDUALS OVER 65 BY TYPE OF NEED, 2015 AND 2020
Figure 1 : FUTURE BURDEN OF ARTHRITIS FOR INDIVIDUALS OVER 65 IN THE U.S. BY GENDER, 2010-2030
Figure 2 : DIABETES INSULIN THERAPY MARKET LEADERS, 2014
Figure 3 : CAUSES OF DEMENTIA IN INDIVIDUALS OVER 65
Figure 4 : PROJECTED LIFETIME LONG-TERM CARE NEEDS FOR INDIVIDUALS OVER 65
Figure 5 : TOP HOME HEALTHCARE PROVIDERS, BY COMPANY AND PERCENT OF MARKET
Figure 6 : PERCENT RANKING OF INDEPENDENT LIVING PROVIDERS BY CAPACITY IN THE U.S., 2014
Figure 7 : U.S. MARKET FOR ASSISTIVE TECHNOLOGY FOR INDIVIDUALS OVER 65, 2015 AND 2020
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll